US Broker Ratings

Merus N.V. (MRUS) Stock Analysis: Biotechnology Innovator with 7.78% Upside Potential

Merus N.V. (NASDAQ: MRUS), a Netherlands-based clinical-stage biotechnology company, is making waves in the healthcare sector with its promising pipeline of bispecific antibody candidates. With a market capitalization of $6.83..

Concentra Group Holdings (CON): Healthcare’s Hidden Gem with a 31.92% Potential Upside

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a prominent player in the healthcare sector, has steadily carved a niche in the medical care facilities industry. Headquartered in Addison, Texas, Concentra..

LifeStance Health Group, Inc. (LFST) Stock Analysis: A 22.61% Upside in the Healthcare Sector

LifeStance Health Group, Inc. (LFST) has been capturing attention in the healthcare sector, particularly among investors keen on the medical care facilities industry. Headquartered in Scottsdale, Arizona, LifeStance Health Group..

ARS Pharmaceuticals, Inc. (SPRY) Investor Outlook: Analyzing the 171% Upside Potential for This Biotech Stock

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) has captured the attention of investors within the healthcare sector, boasting a significant market cap of $1.05 billion and a promising upside potential of 171.24%...

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Evaluating Growth Potential Amidst Market Dynamics

Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider in the healthcare sector, specializes in neonatal and maternal-fetal care services across the United States. With a market capitalization of $1.9..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Compelling Growth Story with 40% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC), a burgeoning player in the medical devices sector, is drawing significant attention from investors seeking opportunities in the healthcare space. With a market capitalization of..

Premier, Inc. (PINC) Investor Outlook: Navigating the 2.97% Dividend Yield Amidst Revenue Decline

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare sector, specializes in health information services in the United States. With a market capitalization of $2.34 billion, Premier operates as..

Guardian Pharmacy Services, Inc (GRDN): Investor Outlook with 29% Upside Potential

Guardian Pharmacy Services, Inc (NASDAQ: GRDN) is capturing investor attention with its remarkable potential upside of nearly 29.49%, according to analyst ratings. As a prominent player in the healthcare sector,..

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Assessing 18% Potential Upside Amid Strategic Advancements

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, continues to capture investor interest with its strategic focus on developing treatments for central nervous system (CNS) disorders..

Vericel Corporation (VCEL) Stock Analysis: Unpacking a 47% Potential Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL) stands out in the biotechnology industry with a compelling narrative centered around innovative cellular therapies and specialty biologic products. Headquartered in Cambridge, Massachusetts, Vericel is carving..

Mirum Pharmaceuticals, Inc. (MIRM) Investor Outlook: Robust Buy Ratings Signal Potential Upside

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) stands out in the biotechnology sector, focusing on the development of therapies for rare and orphan diseases. With a market capitalization of $4.71 billion, this..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Analyzing a Promising 114% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a prominent player in the biotechnology sector focusing on innovative eye care solutions, presents an intriguing opportunity for investors. With its current market cap standing..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A 38.87% Potential Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a prominent player in the biotechnology sector, offers an exciting opportunity for investors eager to explore the healthcare industry’s potential for innovation and growth. Headquartered..

Metsera, Inc. (MTSR) Stock Analysis: Navigating the Biotech Waters with a -19.15% Potential Downside

Metsera, Inc. (MTSR), a clinical-stage biotechnology company, is making waves in the healthcare sector with its pioneering approach to addressing obesity and related disorders. Based in New York and now..

AdaptHealth Corp. (AHCO) Stock Analysis: A Promising 26% Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a crucial player in the healthcare sector, specializes in the distribution of home medical equipment and supplies across the United States. With a robust portfolio that..

SS Innovations International (SSII) Investor Outlook: Exploring the 192.5% Revenue Growth in India’s Booming Medical Device Sector

SS Innovations International Inc. (SSII), a key player in the healthcare sector, is making waves in the medical device industry with its rapid revenue growth and innovative surgical robotics technology...

Vera Therapeutics (VERA) Stock Analysis: Biotech with 61.59% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA) is capturing the attention of investors with its promising potential upside of 61.59%. This clinical-stage biotechnology company is making waves in the healthcare sector with..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 108% Upside in Biotech Innovation

Celldex Therapeutics, Inc. (NASDAQ: CLDX) has captured the attention of investors with its promising biopharmaceutical developments and a notable potential upside of 108.02%. As a key player in the biotechnology..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring its 36.88% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH), a healthcare management company based in Alhambra, California, is making waves in the medical care facilities industry. With a market capitalization of $1.35 billion, Astrana..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 22% Potential Upside in Biotech

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a dynamic player in the biotechnology sector, offers investors a compelling narrative with its strong revenue growth and promising pipeline of dermatological treatments. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds